CN1362196A - Nano Guanxinsuhe medicine and its preparation - Google Patents

Nano Guanxinsuhe medicine and its preparation Download PDF

Info

Publication number
CN1362196A
CN1362196A CN 01100354 CN01100354A CN1362196A CN 1362196 A CN1362196 A CN 1362196A CN 01100354 CN01100354 CN 01100354 CN 01100354 A CN01100354 A CN 01100354A CN 1362196 A CN1362196 A CN 1362196A
Authority
CN
China
Prior art keywords
nano
nanometer
medicine
chinese
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 01100354
Other languages
Chinese (zh)
Inventor
杨孟君
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 01100354 priority Critical patent/CN1362196A/en
Publication of CN1362196A publication Critical patent/CN1362196A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a nano Guanxin-sube preparation medicine. It is made up by using the Chinese medicinal materials of nano liquid storax, nano borneol, nano frankincense, nano sandlwood and nano aristolochia root as raw material through the processes of microwave extraction, reduced pressure concentration and supersonic jet spray drying. Its grain fineness is up to 1200-1500 meshes, grain size is 0.1-200 nm, in which most of grain size is less than 100 nm. Said medicine is high in biological utilization rate and obvious in therapeutic effect.

Description

A kind of nano coronary heart disease treating is revived and is closed preparation medicine and preparation method thereof
The present invention relates to a kind of the chest stuffiness relieving of regulating the flow of vital energy, pain relieving, cure mainly anginal nano coronary heart disease treating Soviet Union and close preparation medicine, the invention still further relates to the method for this medication preparation.
Storax pill for treating coronary heart disease is a kind of classical Chinese patent medicine, mainly contains microcirculation improvement, increases CBSF, improves effects such as hypoxia-bearing capability, decreased heart rate, is used for angina pectoris, the heart is vexed feels suffocated.But traditional storax pill for treating coronary heart disease disintegrate is slower, absorbs not exclusively, and bioavailability is not high, slow curative effect.
The object of the present invention is to provide a kind of bioavailability height, solid dispersion is good, absorbs fully, and preparation medicine closes in the nano coronary heart disease treating of increase evident in efficacy Soviet Union.
Another object of the present invention provides this preparation method that preparation medicine closes in nano coronary heart disease treating Soviet Union.
To achieve these goals, the present invention takes following technical scheme:
Medicine of the present invention is to make (consumption is a weight portion) by following component:
Nano storax 10-40 part nanometer Borneolum Syntheticum 30-70 part nanometer Olibanum 30-70 part
Nanometer Lignum Santali Albi 60-140 part nanometer Radix Aristolochiae 60-140 part
The formula optimization weight proportion scope of medicine of the present invention is:
Nano storax 20-30 part nanometer Borneolum Syntheticum 40-60 part nanometer Olibanum 40-60 part
Nanometer Lignum Santali Albi 80-120 part nanometer Radix Aristolochiae 80-120 part
The optimum weight proportioning of medicine of the present invention is:
52.5 parts of 52.5 parts of nanometer Olibanums of 25 parts of nanometer Borneolum Syntheticums of nano storax
105 parts of 105 parts of nanometer Radix Aristolochiaes of nanometer Lignum Santali Albi
Technical scheme of the present invention is based on the modern material technology.One of modern material Developing Trend in Technology is to develop to the more and more littler direction of yardstick.The granule of the past composition material, its size all are at micron or more than the millimeter magnitude, and have occurred the material to the nanoscale development now.Because extremely refinement of granule, the shared percentage by volume of crystal boundary increases, and makes some performance of material that outstanding variation take place.
The property of nano material be since nano material special construction---the material grains size is less than the ultra-micro powder of 100nm, its body surface area is very big, the atom number ratio at crystal boundary place makes it to produce four big effects up to 15%-50%: i.e. small-size effect, quantum effect (containing macro quanta tunnel effect), skin effect and interfacial effect.Thereby has the not available physical and chemical performance of traditional material.Nanotechnology will bring a technological revolution of the field of Chinese medicines.
One of method of above-mentioned each component being made medicine of the present invention is:
1. divide and get the Chinese crude drug of respectively distinguishing the flavor of, add to concoct according to Chinese Pharmacopoeia one one of version in 2000 and be processed into the common Chinese decoction pieces
2. divide and get the common Chinese decoction pieces of respectively distinguishing the flavor of, be processed into the nanometer prepared slices of Chinese crude drugs, its method comprises the following steps:
1. the common Chinese decoction pieces is placed extraction pot, solubilizer also imports microwave extracting, makes its speed with 20-30 hundred million times/second do the change in polarity motion, and the temperature of its microwave extracting is 30 ℃-60 ℃, time 1-10 hour;
2. above-mentioned extract is carried out concentrating under reduced pressure, temperature is 30 ℃-60 ℃, and the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition;
3. decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 330 meters-990 meter per seconds of effluxvelocity, 30 ℃ of-60 ℃ of temperature, under 0 to 0.05MPa the pressure,, promptly make the nanometer prepared slices of Chinese crude drugs with the instantaneous drying of hypersonic velocity.
3. the nanometer prepared slices of Chinese crude drugs (powder) are prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent standard, make pill, powder, tablet, suppository, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution.
Two of medicine method for making of the present invention is:
1. be equipped with whole common Chinese decoction pieces in the proportioning ratio, place extraction pot, solubilizer also imports microwave extracting, makes its speed with 20-30 hundred million times/second do the change in polarity motion, and the temperature of its microwave extracting is 30 ℃-60 ℃, time 1-10 hour;
2. above-mentioned extract is carried out concentrating under reduced pressure, temperature is 30 ℃-60 ℃, and the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition;
3. decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 330 meters-990 meter per seconds of effluxvelocity, 30 ℃ of-60 ℃ of temperature, under 0 to 0.05MPa the pressure,, get coronary disease Soviet Union and close the preparation nano powder with the instantaneous drying of hypersonic velocity jet;
4. its nano powder is made aforementioned various preparation according to Chinese Pharmacopoeia version standard preparation in 2000.
It is identical that above-mentioned two kinds of methods are made the pharmacological effect that nano coronary heart disease treating Soviet Union closes preparation medicine.
A kind of important feature of the present invention is: the made drug material of the present invention has reached nanoscale, common storax pill for treating coronary heart disease preparation material is micron or the above particle diameter of millimeter, can only cross the 80-120 mesh sieve, the drug material that the present invention is made, particle diameter is at 0.1-200nm, the overwhelming majority can be crossed the 1200-1500 mesh sieve less than 100nm.
Another important feature of the present invention is: solid preparation of the present invention disintegrate rapidly, and solid dispersion is good in water, absorb fully, the bioavailability height, the pharmacological action effect that mainly contains effective constituent is significantly higher than conventional formulation.
The pharmaceutical preparation that the present invention is made does not need to add any adjuvant, and is more favourable to human body.
The present invention has also created the new drug formulation that powder that nano coronary heart disease treating Soviet Union closes preparation medicine, suppository, granule, membrane, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine etc. are had no precedent in the past.
Pharmaceutical preparation of the present invention can be used for angina pectoris, myocardial infarction, also can be used for treatment of conditions such as stomachache, and clinical efficacy significantly is better than traditional storax pill for treating coronary heart disease.
The present invention's added solvent in microwave extracting is water or ethanol.
The present invention carries out in the concentrating under reduced pressure step at extract, and its concentrating under reduced pressure is conventional scheme.
Embodiment 1:
Prepare nano raw material by preceding method:
52.5 parts of 52.5 parts of nanometer Olibanums of 25 parts of nanometer Borneolum Syntheticums of nano storax
105 parts of 105 parts of nanometer Radix Aristolochiaes of nanometer Lignum Santali Albi
Production method is as follows:
In the GMP cleaning shop, after the above-mentioned nanometer prepared slices of Chinese crude drugs or powder prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent capsules agent standard, do not add adjuvant, do not granulate, directly divide encapsulated with the fully-automatic capsule racking machine, make capsule, every capsules content of dispersion is the 0.1-0.6 gram, and the patient takes the 1-5 grain at every turn, and is every with 1-4 time.
Embodiment 2:
Prepare nano raw material by preceding method:
52.5 parts of 52.5 parts of nanometer Olibanums of 25 parts of nanometer Borneolum Syntheticums of nano storax
105 parts of 105 parts of nanometer Radix Aristolochiaes of nanometer Lignum Santali Albi
Production method is as follows:
In the GMP cleaning shop, after the above-mentioned nanometer prepared slices of Chinese crude drugs or powder prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent capsules agent standard, do not add adjuvant, make nano coronary heart disease treating Soviet Union and close powder needle injection, every injection content 5-20 milligram, each consumption is that 1-2 props up, use 1-3 every day.
Embodiment 3:
Prepare nano raw material by preceding method:
52.5 parts of 52.5 parts of nanometer Olibanums of 25 parts of nanometer Borneolum Syntheticums of nano storax
105 parts of 105 parts of nanometer Radix Aristolochiaes of nanometer Lignum Santali Albi
Production method is as follows:
In the GMP cleaning shop, after the above-mentioned nanometer prepared slices of Chinese crude drugs or powder prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent capsules agent standard, filmogen adopts polyvinyl alcohol, make nano coronary heart disease treating Soviet Union and close membrane, every membrane area size 2-100 square centimeter, content of dispersion is the 1-50 gram, every medicine film pasted 1-7 days, pasted the medicine position: abdominal part, back, chest, cervical region.

Claims (6)

1, preparation medicine closes in a kind of nano coronary heart disease treating Soviet Union, it is characterized in that it is the medicament that the nano raw material of following weight proportioning is made:
Nano storax 10-40 part nanometer Borneolum Syntheticum 30-70 part nanometer Olibanum 30-70 part
Nanometer Lignum Santali Albi 60-140 part nanometer Radix Aristolochiae 60-140 part
And adopt following method to make: to select the formula Chinese drug material to concoct and be processed into the prepared slices of Chinese crude drugs; Place extraction pot, solubilizer also imports microwave extracting, makes it do the change in polarity motion with hundred million times/second speed of 20--30, and the temperature of its microwave extracting is 30--60 ℃, time 1--10 hour; Above-mentioned extract is carried out concentrating under reduced pressure, and temperature is 30--60 ℃, and the time is 3--72 hour, collects volatile material in the Chinese medicine simultaneously in addition; Decompressed concentrate and volatile material merging are placed spray drying tower, use the Supersonic fluidics, 30--60 ℃ of temperature, under 0 to 0.05MPa the pressure, with hypersonic velocity instantaneous jet drying, wherein supersonic jet speed is 330 meters-990 meter per seconds, promptly makes the nanometer prepared slices of Chinese crude drugs.
2, nano coronary heart disease treating according to claim 1 is revived and is closed preparation medicine, and wherein the weight proportion of each nano raw material is:
Nano storax 20-30 part nanometer Borneolum Syntheticum 40-60 part nanometer Olibanum 40-60 part
Nanometer Lignum Santali Albi 80-120 part nanometer Radix Aristolochiae 80-120 part
3, nano coronary heart disease treating according to claim 1 is revived and is closed preparation medicine, and wherein the weight proportion of each nano raw material is:
52.5 parts of 52.5 parts of nanometer Olibanums of 25 parts of nanometer Borneolum Syntheticums of nano storax
105 parts of 105 parts of nanometer Radix Aristolochiaes of nanometer Lignum Santali Albi
4, close preparation medicine according to claim 1 or 2 or 3 described nano coronary heart disease treatings Soviet Union, it is characterized in that said medicine is pill, powder, tablet, suppository, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution.
5, the pharmaceutical methods of closing preparation medicine according to claim 1 or 2 or 3 described nano coronary heart disease treatings Soviet Union is characterized in that this method comprises the steps: to select the formula Chinese drug material to concoct and is processed into the prepared slices of Chinese crude drugs; Place extraction pot, solubilizer also imports microwave extracting, makes it do the change in polarity motion with hundred million times/second speed of 20--30, and the temperature of its microwave extracting is 30--60 ℃, time 1--10 hour; Above-mentioned extract is carried out concentrating under reduced pressure, and temperature is 30--60 ℃, and the time is 3--72 hour, collects volatile material in the Chinese medicine simultaneously in addition; Decompressed concentrate and volatile material merging are placed spray drying tower, use the Supersonic fluidics, 30--60 ℃ of temperature, under 0 to 0.05MPa the pressure, with hypersonic velocity instantaneous jet drying, wherein supersonic jet speed is 330 meters-990 meter per seconds, promptly makes the nanometer prepared slices of Chinese crude drugs.
6, wherein respectively distinguish the flavor of Chinese medicine in the ratio of prescription or Chinese crude drug concoct be processed into the prepared slices of Chinese crude drugs after mixing, or after making the nanometer prepared slices of Chinese crude drugs mixing.
CN 01100354 2001-01-02 2001-01-02 Nano Guanxinsuhe medicine and its preparation Pending CN1362196A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 01100354 CN1362196A (en) 2001-01-02 2001-01-02 Nano Guanxinsuhe medicine and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 01100354 CN1362196A (en) 2001-01-02 2001-01-02 Nano Guanxinsuhe medicine and its preparation

Publications (1)

Publication Number Publication Date
CN1362196A true CN1362196A (en) 2002-08-07

Family

ID=4651523

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 01100354 Pending CN1362196A (en) 2001-01-02 2001-01-02 Nano Guanxinsuhe medicine and its preparation

Country Status (1)

Country Link
CN (1) CN1362196A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102100807B (en) * 2008-03-28 2012-10-31 北京亚东生物制药有限公司 Chinese medicine composition for regulating qi, widening chest and relieving pain as well as detection method thereof
CN104435050A (en) * 2014-11-26 2015-03-25 黑龙江省智诚医药科技有限公司 Traditional Chinese medicine compound powder for treating stenocardia and preparation method thereof
CN104523805A (en) * 2014-12-30 2015-04-22 海南葫芦娃制药有限公司 Storax dispersible tablet for coronary heart disease and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102100807B (en) * 2008-03-28 2012-10-31 北京亚东生物制药有限公司 Chinese medicine composition for regulating qi, widening chest and relieving pain as well as detection method thereof
CN104435050A (en) * 2014-11-26 2015-03-25 黑龙江省智诚医药科技有限公司 Traditional Chinese medicine compound powder for treating stenocardia and preparation method thereof
CN104523805A (en) * 2014-12-30 2015-04-22 海南葫芦娃制药有限公司 Storax dispersible tablet for coronary heart disease and preparation method thereof
CN104523805B (en) * 2014-12-30 2018-01-16 海南葫芦娃药业集团股份有限公司 Dispersible tablet and preparation method thereof closes in coronary disease Soviet Union

Similar Documents

Publication Publication Date Title
CN1362196A (en) Nano Guanxinsuhe medicine and its preparation
CN1362084A (en) Nano coronary heart disease treating red sage medicine and its preparation
CN1362151A (en) Nano Mayinglong pile-treating musk medicine and its preparation
CN1368208A (en) Nano medicine 'Ganfu' and its preparing process
CN1362199A (en) Nano girald daphne medicine and its preparation
CN1362141A (en) Nano Xingxiao bezoar medicine and its preparation
CN1365676A (en) Nano medicine 'Compound berberine' and its preparing process
CN1362191A (en) Nano Folium Ginkgo medicine and its preparation
CN1365782A (en) Nano medicine 'Rukuaixiao' and its preparing process
CN1362139A (en) Nano Pingxiao medicine and its preparation
CN1364500A (en) Nano sanliangban medicine and its preparing method
CN1368071A (en) Nano medicine 'Qianzihong' and its preparing process
CN1362193A (en) Namo xinkeshu medicine and its preparation
CN1362248A (en) Nano stomach-calming medicine of Aucklandiae and Amomi and its preparation
CN1363297A (en) Nano medicine 'Anluotong' and its preparing process
CN1362147A (en) Nano mixed red sage medicine and its preparation
CN1366888A (en) Nano quicken the blood and disperse welling abscess preparation medicine and preparation method thereof
CN1365736A (en) Nano medicine for treating coronary heart disease and its preparing process
CN1362226A (en) Nano medicine of ten medicinal plant ashes and its preparation
CN1363286A (en) Nano musk medicine for protecting heart and its preparing process
CN1362159A (en) Nano shuxin syrup and preparation
CN1362197A (en) Nano Diaoxinxuekang medicine and its preparation
CN1362240A (en) Nano medicine powder for treating cold limbs caused by Yang exhaustion and its preparation
CN1362120A (en) Nano wound-healing motoginseng medicine and its preparation
CN1366900A (en) Nano lingbao huxin preparation medicine and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication